SCHEMBL1611075

SCHEMBL1611075

CCOC(=O)[C@H](CSc1ccccc1)Nc1nc(C2CC2)nc(C(=O)OC)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.39
KDM4E B2RXH2 2/20 0.39
PDE10A Q9Y233 3/20 0.37
TSHR P16473 3/20 0.37
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 7/20 0.33
MAPT P10636 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HSD17B10 Q99714 3/20 0.33
RECQL P46063 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1611073 1.00 L3MBTL1 (0.39) L3MBTL1KDM4EPDE10ATSHRMAPK1
SCHEMBL1608935 0.82 SMN1; SMN2 (0.41) L3MBTL1KDM4EPDE10ATSHRMAPK1
SCHEMBL1609302 0.79 PDE10A (0.43) L3MBTL1PDE10ATSHRALDH1A1HSD17B10
SCHEMBL12738485 0.78 PDE10A (0.43) PDE10AALDH1A1MEN1KMT2ATDP1
SCHEMBL1609732 0.77 PDE10A (0.39) KDM4EPDE10ATSHRMAPK1ALDH1A1
SCHEMBL1609362 0.77 PDE10A (0.40) L3MBTL1KDM4EPDE10ATSHRMAPK1
SCHEMBL1609830 0.76 ELANE (0.40) KDM4EPDE10ATSHRMAPK1ALDH1A1
SCHEMBL1610170 0.76 PDE10A (0.50) KDM4EPDE10ATSHRMAPK1ALDH1A1
SCHEMBL12712958 0.76 CYP3A4 (0.43) KDM4EPDE10AMAPK1MAPTMEN1
SCHEMBL1611523 0.75 EGFR (0.39) PDE10ATSHRMAPK1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed
WO-2009081112-A2 CHEMICAL COMPOUNDS SYNGENTA LIMITED (GB) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 L3MBTL1 1885/4885KDM4E 2613/4885PDE10A 1704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.